HomeCBIO • NASDAQ
add
Crescent Biopharma Inc
Previous close
$11.49
Day range
$10.92 - $11.59
Year range
$8.72 - $28.69
Market cap
310.01M USD
Avg Volume
203.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 10.84M | — |
Operating expense | 102.34M | 602.86% |
Net income | -92.40M | -506.44% |
Net profit margin | -852.06 | — |
Earnings per share | -4.92 | — |
EBITDA | -91.44M | — |
Effective tax rate | -2.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 213.19M | 513.22% |
Total assets | 240.29M | 574.66% |
Total liabilities | 37.28M | -20.84% |
Total equity | 203.01M | — |
Shares outstanding | 33.21M | — |
Price to book | 1.92 | — |
Return on assets | -120.84% | — |
Return on capital | -141.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -92.40M | -506.44% |
Cash from operations | -26.74M | — |
Cash from investing | -72.19M | — |
Cash from financing | 178.86M | — |
Net change in cash | 79.93M | — |
Free cash flow | -130.99M | — |
About
Founded
2024
Headquarters
Website
Employees
41
